Literature DB >> 7948196

A modified serum neutralization test for the detection of antibody to porcine reproductive and respiratory syndrome virus in swine sera.

I J Yoon1, H S Joo, S M Goyal, T W Molitor.   

Abstract

Various conditions were evaluated and modified to improve the sensitivity of the serum neutralization (SN) test for detecting antibody in pigs infected with porcine reproductive and respiratory syndrome virus (PRRSV). Higher SN titers were consistently obtained by the addition of 20% fresh swine serum to the virus diluent and by the use of a permissive cell clone (MARC-145) derived from the MA-104 cell line. Test sera used to assess the SN test were obtained from 2 groups of 3-week-old pigs infected intranasally with PRRSV (MN-1b). Using the modified method, SN antibody was first detected 9-11 days postinoculation (PI), with a peak evident at 11-21 days PI. The antibody subsequently declined, and a second peak was observed between 41 and 45 days PI. The first antibody peak was not observed and the SN antibody was only detectable between 32 and 41 days PI when the test was done with 20% heated swine serum or without supplemental swine serum. The SN antibody during 2-3 weeks PI was found to be sensitive to 2-mercaptoethanol or anti-swine IgM treatment. The SN antibody titers were high when homologous PRRSV isolate was used in the test but were markedly low for heterologous PRRSV isolates. No difference in antibody titers was observed when homologous and heterologous PRRSV isolates were tested by indirect fluorescent antibody assay. These results indicate that the modified SN method is useful in detecting earlier and higher PRRSV antibody and that it can differentiate among PRRSV isolates.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7948196     DOI: 10.1177/104063879400600326

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  57 in total

1.  Evaluation of the new commercial recombinant chimeric subunit vaccine PRRSFREE in challenge with heterologous types 1 and 2 porcine reproductive and respiratory syndrome virus.

Authors:  Jiwoon Jeong; Changhoon Park; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2017-01       Impact factor: 1.310

2.  Epitope mapping porcine reproductive and respiratory syndrome virus by phage display: the nsp2 fragment of the replicase polyprotein contains a cluster of B-cell epitopes.

Authors:  M B Oleksiewicz; A Bøtner; P Toft; P Normann; T Storgaard
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Comparison of Two Commercial Type 1 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) Modified Live Vaccines against Heterologous Type 1 and Type 2 PRRSV Challenge in Growing Pigs.

Authors:  Taeyeon Kim; Changhoon Park; Kyuhyung Choi; Jiwoon Jeong; Ikjae Kang; Su-Jin Park; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2015-04-08

4.  Carbon Monoxide Inhibits Porcine Reproductive and Respiratory Syndrome Virus Replication by the Cyclic GMP/Protein Kinase G and NF-κB Signaling Pathway.

Authors:  Angke Zhang; Lijuan Zhao; Na Li; Hong Duan; Hongliang Liu; Fengxing Pu; Gaiping Zhang; En-Min Zhou; Shuqi Xiao
Journal:  J Virol       Date:  2016-12-16       Impact factor: 5.103

5.  Effectiveness of a commercial porcine reproductive and respiratory syndrome virus (PRRSV) subunit vaccine against heterologous PRRSV-1 and PRRSV-2 challenge in late-term pregnant gilts.

Authors:  Taehwan Oh; Hanjin Kim; Kee Hwan Park; Jiwoon Jeong; Ikjae Kang; Siyeon Yang; Chanhee Chae
Journal:  Can J Vet Res       Date:  2019-10       Impact factor: 1.310

6.  Porcine Reproductive and Respiratory Syndrome Virus Utilizes Nanotubes for Intercellular Spread.

Authors:  Rui Guo; Benjamin B Katz; John M Tomich; Tom Gallagher; Ying Fang
Journal:  J Virol       Date:  2016-04-29       Impact factor: 5.103

7.  Evaluation of a DNA vaccine candidate co-expressing GP3 and GP5 of porcine reproductive and respiratory syndrome virus (PRRSV) with interferon α/γ in immediate and long-lasting protection against HP-PRRSV challenge.

Authors:  Yijun Du; Jing Qi; Yu Lu; Jiaqiang Wu; Dongwan Yoo; Xing Liu; Xiumei Zhang; Jun Li; Wenbo Sun; Xiaoyan Cong; Jianli Shi; Jinbao Wang
Journal:  Virus Genes       Date:  2012-07-28       Impact factor: 2.332

8.  Kinetics of humoral immune response to the major structural proteins of the porcine reproductive and respiratory syndrome virus.

Authors:  H D Loemba; S Mounir; H Mardassi; D Archambault; S Dea
Journal:  Arch Virol       Date:  1996       Impact factor: 2.574

9.  Comparison of 2 commercial single-dose Mycoplasma hyopneumoniae vaccines and porcine reproductive and respiratory syndrome virus (PRRSV) vaccines on pigs dually infected with M. hyopneumoniae and PRRSV.

Authors:  Changhoon Park; Ikjae Kang; Hwi Won Seo; Jiwoon Jeong; Kyuhyung Choi; Chanhee Chae
Journal:  Can J Vet Res       Date:  2016-04       Impact factor: 1.310

10.  A new modified live porcine reproductive and respiratory syndrome vaccine improves growth performance in pigs under field conditions.

Authors:  Changhoon Park; Hwi Won Seo; Ikjae Kang; Jiwoon Jeong; Kyuhyung Choi; Chanhee Chae
Journal:  Clin Vaccine Immunol       Date:  2014-07-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.